Misc Covid-19 Resources

Cambridge University Press Resources

Cambridge University Press have set up free-of-charge online resources to help NUST staff and students overcome the disruption caused by the global response to the Covid-19 pandemic. This includes free access to HTML textbooks, Cambridge Histories, Cambridge Companions and Cambridge Elements, through to 31st May.

Below various links to the content:

A full list of 700+ HTML textbooks published on the platform can be found here

Cambridge Companions

Cambridge Histories

Cambridge Elements

In addition, they are providing free access to coronavirus research on Cambridge Core. More than 80 relevant book chapters and journal articles are currently in the collection, with future articles being added once they are published:

The Press has also joined other publishers in signing a commitment to make the research available through PubMed Central and other public repositories of journal literature.

More details on the response to the COVID-19 pandemic from the Press’s Academic Publishing group can be found here:

ICOLC statement on the Global COVID-19 Pandemic

The ICOLC statement on the Global COVID-19 Pandemic, calls on publishers and content providers to make any relevant information and data sets about COVID-19, Coronaviruses, vaccines, antiviral drugs, etc. Open Access immediately. 

E Resources Center

Print: Print resources available for users include journals, newsletters, newspapers, annual reports, memoirs, transactions, and proceedings of societies. All print resources are for library use only. Patrons can borrow a maximum of 1 newspaper and 3 journals at a time.

EBSCO Faculty Select

What is Faculty Select?

Faculty Select is a single interface where faculty can easily discover and access Open Educational Resources (OER), as well as find and request access to unrestricted, DRM-free e-books from top academic publishers.

With this option, EBSCO is offering a simplified version of Faculty Select that includes access to OER material as well as the option to discover more than 225,000 DRM-free EBSCO eBooks™ in one place, available at no charge for faculty to use through June 30, 2020. Contact your EBSCO representative if you have any questions or want to learn more.

Faculty can use this link to access now.

How will it work?

  • Faculty can then click the above link to access the simplified version of Faculty Select.
  • Faculty can then search more than 12,400 Open Educational Resources, and copy/paste links to relevant materials into their Learning Management System (LMS) or send links to the material directly to students to access.
  • Faculty can also search and discover more than 225,000 DRM-free EBSCO eBooks; if they discover an e-book of interest, they can contact their librarian to discuss potentially purchasing.
EIFL’S response to the Covid-19 pandemic

In response to the COVID-19 pandemic, EIFL is working with its partners globally to help ensure that education and research continue despite disruptions, and that the scientific and health sectors have access to the widest range of trusted resources to support their work while the crisis continues.

EBSCO Covid 19 Free Resources

To access free and expanded resources today, visit our COVID-19 resource site.

Oxford Journals Archive.
Gain access to the Oxford Journals Archive. The Oxford Journals Archive includes over a century of content at the forefront of academic research and the 2020 collection includes four new journals featured below.   Learn More    
Highlights of the Oxford Journals Archive:
248 high-quality journals
Five subject areas: Medicine, Science, Humanities, Social Sciences and Law
Over 40,000 issues and 1,00,000 articles
More than 260 Nobel Prize-winning authors

Elsevier Coronavirus Research Hub

Elsevier adds to its extensive free resources for biomedical and scientific researchers working on coronavirus with access to broad suite of tools. The Elsevier Coronavirus Research Hub includes access to multiple tools, from scientific and clinical content to COVID-19 specific datasets, text mining services and more

Elsevier (https://www.elsevier.com/), a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and life science companies accelerate efforts to address the current pandemic.

The new Elsevier Coronavirus Research Hub (https://www.elsevier.com/clinical-solutions/coronavirus-research-hub) currently includes a biomedical database, scientific and clinical content, COVID-19-specific datasets, a biomedically-focused text mining solution and several research collaboration tools, with more tools coming soon.

The Elsevier Coronavirus Research Hub is freely available here- https://www.elsevier.com/coronavirus-research-hub

The Hub currently includes free access to Embase, ClinicalKey, Mendeley, Mendeley Data, the Pure COVID-19 Research Collaboration Center, SSRN and Elsevier Text Mining (MedScan). Access to other Elsevier solutions including Pathway Studio, Reaxys and Reaxys Medicinal Chemistry and Veridata EDC (Electronic Data Capture) is coming soon. Access is available through October 28, 2020.

Elsevier's Novel Coronavirus Information Center

Elsevier’s Novel Coronavirus Information Center (http://www.elsevier.com/connect/coronavirus-information-center) provides the newest expert, curated information for the research and health communities on Novel Coronavirus (also referred to as COVID-19 and its temporary title 2019-nCoV).

Elsevier's ScienceDirect

Elsevier’s ScienceDirect (https://www.sciencedirect.com/), where more than 21,000 research articles relevant to Coronavirus, SARS, and MERS are freely available. For the healthcare community, the Elsevier COVID-19 Healthcare Hub (https://covid-19.elsevier.health/index.html) provides clinicians and patients free access to toolkits, expert insights, research resources and COVID-19 guidelines as well as FAQs on symptoms.

For more on Elsevier’s coronavirus initiatives, see this Elsevier Connect story (https://www.elsevier.com/connect/coronavirus-initiatives).